Mohammed T. Abou-Saleh

362 PRINCIPLES AND PRACTICE OF GERIATRIC PSYCHIATRY30. Hayden MR, Hewitt J, Stoessl AJ et al. The combined use of positronemission tomography and DNA polymorphisms for preclinicaldetection of Huntington’s disease. Neurology 1987; 37(9): 1441–7.31. Lawrence AD, Weeks RA, Brooks DJ et al. The relationship betweenstriatal dopamine receptor binding and cognitive performance inHuntington’s disease. Brain 1998; 121: 1343–55.32. Mazziotta JC, Phelps ME, Pahl JJ et al. Reduced cerebral glucosemetabolism in asymptomatic subjects at risk for Huntington’s disease.N Engl J Med 1987; 316(7): 357–62.33. Kremer B, Clark CM, Almqvist EW et al. Influence of lamotrigine onprogression of early Huntington disease: a randomized clinical trial.Neurology 1999; 53(5): 1000–11.34. Bartenstein P, Weindl A, Spiegel S et al. Central motor processing inHuntington’s disease. A PET study. Brain 1997; 120: 1553–67.35. Weeks RA, Ceballos-Baumann AO, Piccini P et al. Cortical control ofmovement in Huntington’s disease. A PET activation study. Brain1997; 120: 1569–78.36. Soares JC, Mann JJ. The functional neuroanatomy of mooddisorders. J Psychiat Res 1997; 31(4): 393–432.37. Mayberg HS. Limbic-cortical dysregulation: a proposed model ofdepression. J Neuropsychiatr Clin Neurosci 1997; 9: 471–81.38. Kumar A, Newberg A, Alavi A et al. Regional cerebral glucosemetabolism in late-life depression and Alzheimer disease: apreliminary positron emission tomography study. Proc Natl AcadSci USA 1993; 90(15): 7019–23.39. Nobler MS, Mann JJ, Sackeim HA. Serotonin, cerebral blood flow,and cerebral metabolic rate in geriatric major depression and normalaging. Brain Res–Brain Res Rev 1999; 30(3): 250–63.40. Biver F, Wikler D, Lotstra F et al. Serotonin 5-HT 2 receptor imagingin major depression: focal changes in orbito-insular cortex. Br JPsychiat 1997; 171: 444–8.41. Meyer JH, Kapur S, Houle S et al. Prefrontal cortex 5-HT 2 receptorsin depression: an [18F]setoperone PET imaging study. Am J Psychiat1999; 156(7): 1029–34.42. Meltzer CC, Smith G, Price JC et al. Reduced binding of[18F]altanserin to serotonin type 2A receptors in aging:persistence of effect after partial volume correction. Brain Res1998; 813(1): 167–71.43. Meltzer CC, Price JC, Mathis CA et al. PET imaging of serotonintype 2A receptors in late-life neuropsychiatric disorders. Am JPsychiat 1999; 156(12): 1871–8.